Day: March 9, 2026

us corporate news

Lightpath Fiber Issuer LLC Secured Fiber Network Revenue Notes Indenture Agreement – Definitions, Covenants, and Regulatory Compliance (2026)

Minichart

March 9, 2026

Optimum Communications, Inc. - Detailed Investor Report ...

Continue Reading 0

us corporate news

Xenon Pharmaceuticals Announces Positive Phase 3 Results for Azetukalner in Focal Onset Seizures, Plans FDA Submission in Q3 2026 12

Minichart

March 9, 2026

Xenon Pharmaceuticals Announces Exceptionally Positive Phase...

Continue Reading 0

us corporate news

Lisata Therapeutics to Be Acquired by Kuva Labs for $5.00 Per Share Plus Potential $1.00 CVR in 2026 Merger Deal

Minichart

March 9, 2026

Lisata Therapeutics to be Acquired by Kuva Labs in \$5.00 pe...

Continue Reading 0

us corporate news

Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results, Highlights Promising CRB-701 and CRB-913 Clinical Updates and Extends Cash Runway Into 2028

Minichart

March 9, 2026

Corbus Pharmaceuticals Q4 2025 Earnings and Corporate Update...

Continue Reading 0

us corporate news

Heritage Insurance Holdings Reports Record Q4 and Full-Year 2025 Results with 228% Net Income Growth and Strategic Expansion Plans

Minichart

March 9, 2026

Heritage Insurance Holdings Reports Record Fourth Quarter an...

Continue Reading 0

us corporate news

InMed Pharmaceuticals Advances INM-901 for Alzheimer’s and INM-089 for Macular Degeneration with FDA Engagement Planned for 2026-2027 1

Minichart

March 9, 2026

InMed Pharmaceuticals 2026 Development Update: Key Highlight...

Continue Reading 0

us corporate news

American Express Global Business Travel Reports Strong Financial Performance for Q4 and FY 2025 – Earnings, EBITDA, and Key Metrics Explained

Minichart

March 9, 2026

American Express Global Business Travel Group 2025 Earnings ...

Continue Reading 0

us corporate news

FTI Consulting Appoints Angela Nam as New Chief Financial Officer Effective May 2026

Minichart

March 9, 2026

FTI Consulting Appoints Angela Nam as CFO: Key Details for I...

Continue Reading 0

us corporate news

European Commission Approves Once-Every-Four-Weeks Elfabrio® (Pegunigalsidase Alfa) Dosing for Fabry Disease, Reducing Treatment Burden for Adults

Minichart

March 9, 2026

Protalix & Chiesi Announce Major EU Approval for Elfabrio ...

Continue Reading 0

us corporate news

Strategy Inc (Formerly MicroStrategy) Announces ATM Offering Update and Bitcoin Holdings Disclosure in March 2026 8-K Filing

Minichart

March 9, 2026

Strategy Inc. (formerly MicroStrategy) Files Form 8-K: ATM O...

Continue Reading 0